Ching Yi Wang

Ching Yi Wang currently works at StemCyte, Inc., as Independent Director from 2013, the University of Yuan Ze, as Director, DDM Social Welfare & Charity Foundation, as Director, T N Soong Foundation, as Director, Sung Tso Nan Memorial Foundation, as Director, Shanghai Commercial & Savings Bank Cultural & Educational Fdn, as Director, and SunWay Biotech Co., Ltd., as Independent Director from 2020.
Mr. Wang also formerly worked at Deloitte & Touche, as Chairman, T N Soong & Co., as Chairman & Managing Partner, Asia Cement Corp., as Director-Supervisory Board, China Steel Corp., as Director-Supervisory Board, China Airlines Ltd., as Director-Supervisory Board, Chung Hwa Pulp Corp., as Director-Supervisory Board, Vanguard International Semiconductor Corp., as Director, Mirle Automation Corp., as Director from 2010 to 2012, Prime View International Co. Ltd., as Director-Supervisory Board, E Ink Holdings, Inc., as Director-Supervisory Board from 2008 to 2013, SinoPac Financial Holdings Co., Ltd., as Member-Supervisory Board, Motech Industries, Inc., as Member-Supervisory Board, Taiwan High Speed Rail Corp., as Member-Supervisory Board, Bank SinoPac Co., Ltd., as Member-Supervisory Board in 2012, and Eli C.
Wang & Co. CPAs, as Managing Partner.
Mr. Wang received his graduate degree from the University of Illinois and undergraduate degree from National Cheng Kung University.